Back to Search
Start Over
Outcome of Clinical Genetic Testing in Patients with Features Suggestive for Hereditary Predisposition to PTH-mediated Hypercalcemia
- Source :
- Horm Cancer
- Publication Year :
- 2020
-
Abstract
- Primary hyperparathyroidism (pHPT) is associated with familial syndromes such as multiple endocrine neoplasia type 1 (MEN1), 2A (MEN2A), MEN-like syndromes (CDKN1B), and CDC73-related disorder (hyperparathyroidism – jaw tumor syndrome (HPJT)). Familial hypocalciuric hypercalcemia (FHH) caused by CASR variants is an important differential diagnosis for pHPT. In order to evaluate the contribution of hereditary causes to pHPT in patients encountered in a specialized clinic, we conducted a retrospective study on patients with pHPT that underwent germline genetic testing. We evaluated 46 patients referred to a Cancer Genetics Clinic. Reasons for referral were young age (age
- Subjects :
- 0301 basic medicine
Parathyroidectomy
Adult
Cancer Research
medicine.medical_specialty
endocrine system diseases
Endocrinology, Diabetes and Metabolism
medicine.medical_treatment
Article
03 medical and health sciences
0302 clinical medicine
Endocrinology
Internal medicine
Medicine
Humans
Genetic Predisposition to Disease
Genetic Testing
Family history
Multiple endocrine neoplasia
Genetic testing
Hyperparathyroidism
medicine.diagnostic_test
Familial hypocalciuric hypercalcemia
Endocrine and Autonomic Systems
business.industry
medicine.disease
Hyperparathyroidism, Primary
030104 developmental biology
Treatment Outcome
Oncology
030220 oncology & carcinogenesis
Hypercalcemia
Differential diagnosis
business
Primary hyperparathyroidism
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Horm Cancer
- Accession number :
- edsair.doi.dedup.....6df355a8e8206354150b7795686e3fd0